The DOI matches its Crossref record; 345 of the 345 references it cites were found in a registry or an index.
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
Open accessAbstract
The Wnt/β-catenin pathway comprises a family of proteins that play critical roles in embryonic development and adult tissue homeostasis. The deregulation of Wnt/β-catenin signalling often leads to various serious diseases, including cancer and non-cancer diseases. Although many articles have reviewed Wnt/β-catenin from various aspects, a systematic review encompassing the origin, composition, function, and clinical trials of the Wnt/β-catenin signalling pathway in tumour and diseases is lacking. In this article, we comprehensively review the Wnt/β-catenin pathway from the above five aspects in combination with the latest research. Finally, we propose challenges and opportunities for the development of small-molecular compounds targeting the Wnt signalling pathway in disease treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The inactivation of GSK3β disrupts the integrity and function of the destruction complex, thereby preventing β-catenin phosphorylation. As a result, unphosphorylated, stable β-catenin accumulates in the cytoplasm, translocates to the nucleus, and activates the transcription of its target genes, including c-Myc and Cyclin D1 [35, 46, 47, 52–55].”
From PPP1R18-mediated activation of Wnt/β-catenin and EMT is dependent on ERK signaling in clear cell renal cell carcinoma (2026) · cites this paper as [53]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Wnt signaling is a critical pathway involved in multiple developmental processes and can also contribute to malignant transformation.”
From Multiple myeloma: signaling pathways and targeted therapy (2024) · cites this paper as [64]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“For example, resistance training reduces muscle atrophy by inhibiting complement component 1q (C1q)-induced Wnt signaling as well as the PI3K-Akt-tuberous sclerosis complex (TSC) cascade, which regulates the activity of the target of rapamycin complex 1 (mTORC1) via the Ras homolog enriched in the brain (Rheb)”
From Exercise-Induced Muscle–Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging (2025) · cites this paper as [93]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Resistance training in mice attenuates muscle fibrosis and atrophy by suppressing C1q-induced Wnt/β-catenin signaling, specifically through the glycogen synthase kinase-3 beta (GSK)-3β/β-catenin axis”
From Exercise-Induced Muscle–Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging (2025) · cites this paper as [93]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia
Román-Gómez, J., Cordeu, L., Agirre, X., Jiménez-Velasco, A., San José-Eneriz, E., Garate, L., Calasanz, M. J., Heiniger, A., Torres, A., & Prosper, F. (2007) · Blood · doi:10.1182/blood-2006-09-047043 · Cited by 168 · cited 1×
“The results indicate the role of abnormal Wnt signalling in ALL and establish a group of patients with a significantly worse prognosis (methylated group).(253)”
BackgroundRetractedSatō, Y., Asoh, T., & Oizumi, K. (1998) · Bone · doi:10.1016/s8756-3282(98)00134-3 · Cited by 140 · cited 2×
“Fourteen bone-related biomarkers in elderly people with memory problems were not clinically diagnosed with asymptomatic AD, and the expression of TRAIL and DKK1 was elevated in the brain.(257,258) Wnt signalling has a neuroprotective effect, and DKK1, as an antagonist of the canonical Wnt signalling pathway, is negati…”
BackgroundResultRetractedFu, X., Zhu, X., Qin, F., Zhang, Y., Lin, J., Ding, Y., Yang, Z., Shang, Y., Wang, L., Zhang, Q., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0783-3 · Cited by 109 · cited 1×
“The lncRNAs Linc00210 and lncRNA-CCAL inhibit the activity of CTNNBIP1 and activator protein-2α (AP-2α), respectively, and block the binding of CTNNBIP1 and AP-2α to β-catenin, enhancing the interaction between β-catenin and the TCF/LEF complex.(67,68) LncRNA-NEAT1 interacts with DDX5 and promotes the formation of a c…”
BackgroundRetractedLiu, B., Wu, S., Han, L., & Zhang, C. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2382 · Cited by 25 · cited 3×
“The absence of Wnt signalling inhibits the nuclear transport of β-catenin mediated by ZBP1, resulting in a decrease in Runx2 and Sp7 (osteogenic factors) expression in mouse bone marrowderived MSCs.132,133 DHCR7 and INSIG1/2 are related to the effect of cholesterol metabolism on bone formation.”
BackgroundRetractedIdentification of stem cells in small intestine and colon by marker gene Lgr5
Barker, N., van Es, J. H., Kuipers, J., Kujala, P., van den Born, M., Cozijnsen, M., Haegebarth, A., Korving, J., Begthel, H., Peters, P. J., et al. (2007) · Nature · doi:10.1038/nature06196 · Cited by 5,687
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
Wnt/β-Catenin Signaling in Development and Disease
Clevers, H. (2006) · Cell · doi:10.1016/j.cell.2006.10.018 · Cited by 5,568
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
Nusse, R., & Clevers, H. (2017) · Cell · doi:10.1016/j.cell.2017.05.016 · Cited by 4,342
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.275.5307.1787 · Cited by 3,942
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Spranger, S., Bao, R., & Gajewski, T. F. (2015) · Nature · doi:10.1038/nature14404 · Cited by 2,830 · cited 1×
“Using a mouse melanoma model, the researchers confirmed that the intrinsically active β-catenin signal of the tumour led to T cell rejection and resistance to anti-PD-L1/anti-CTLA-4 monoclonal antibody treatment.(301) Simultaneously, the analysis of primary melanoma lesions with BRAF mutations showed that T cell infil…”
Background
Research works printed but not linked: 8
- Amemiya, T., Tsuboi, M. & Uchida, S. Electron microscopic and electron histochemical studies on embryonal rhabdomyosarcoma of the orbit. Zeitschrift fur Krebsforschung und klinische. Onkol. Cancer Res. Clin. Oncol. 83, 305–314 (1975).
- Cruciat, C. M. & Niehrs, C. Secreted and transmembrane wnt inhibitors and activators[J]. Cold Spring Harb. Perspect. Biol. 5, a015081 (2013). · DOI · Paper page
- Malinauskas, T. et al. Modular mechanism of Wnt signaling inhibition by Wnt inhibitory factor 1[J]. Nat. Struct. Mol. Biol. 18, 886–893 (2011). · DOI · Paper page
- Jiang, X. et al. Dishevelled promotes Wnt receptor degradation through recruitment of ZNRF3/RNF43 E3 ubiquitin ligases[J]. Mol. Cell 58, 522–533 (2015). · DOI · Paper page
- Kwon, C. et al. Notch post-translationally regulates β-catenin protein in stem and progenitor cells[J]. Nat. cell Biol. 13, 1244–1251 (2011). · DOI · Paper page
- Jimeno, A. et al. A First-in-Human Phase I Study of the Anticancer Stem Cell Agent Ipafricept (OMP-54F28), a Decoy Receptor for Wnt Ligands, in Patients with Advanced Solid Tumors. Clin. Cancer Res. : Off. J. Am. Assoc. Cancer Res. 23, 7490–7497 (2017). · DOI · Paper page
- Arensman, M. et al. The CREB-binding protein inhibitor ICG-001 suppresses pancreatic cancer growth. Mol. cancer therapeutics 13, 2303–2314 (2014). · DOI
- Emami, K. et al. A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]. Proc. Natl Acad. Sci. USA 101, 12682–12687 (2004). · DOI · Paper page
Cited by
NF-κB in biology and targeted therapy: new insights and translational implications
Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01757-9 · Cited by 2,047
“151,152 In contrast, it has been revealed that Dvl interacts with p65 in the nucleus and inhibits NF-κ B-mediated transcriptional activation, and promotes apoptosis, independently of Wnt or β -catenin.”
BackgroundLu, P., Ruan, D., Huang, M., Tian, M., Zhu, K., Gan, Z., & Xiao, Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01852-x · Cited by 667
Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets
Di, X., Gao, X., Peng, L., Ai, J., Jin, X., Qi, S., Li, H., Wang, K., & Luo, D. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01501-9 · Cited by 622
Fleishman, J. S., & Kumar, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01811-6 · Cited by 544
Cell-cell communication: New insights and clinical implications
Su, J., Song, Y., Zhu, Z., Huang, X., Fan, J., Qiao, J., & Mao, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01888-z · Cited by 433
Metadata
- Authors
- Liu, J., Xiao, Q., Xiao, J., Niu, C., Li, Y., Zhang, X., Zhou, Z., Shu, G., & Yin, G.
- Affiliations
- Central South University (CN)
- Corresponding author
- Yin, Gang
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2022-01-03
- Volume
- 7
- Issue
- 1
- Pages
- 3-3
- ISSN
- 2059-3635 (ISSN-L)
- PMC
- PMC8724284
- OpenAlex
- W4205498896
- Cited by
- 2,519
- References
- 345
- Citations by year
- 2026: 571 · 2025: 859 · 2024: 704 · 2023: 317 · 2022: 65
- FWCI
- 50.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Signal Transduction and Targeted Therapy (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
- Keywords
- Wnt/β-catenin signaling, Wnt proteins, β-catenin, embryonic development, tissue homeostasis, cancer, non-cancer diseases, small molecule inhibitors, therapeutic target, clinical trials
- MeSH terms
- Animals, Humans, Neoplasm Proteins, Neoplasms, Wnt Proteins, beta Catenin, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. https://app.cochat.ai/papers/10.1038/s41392-021-00762-6
- The paper
- Liu, J., Xiao, Q., Xiao, J., Niu, C., Li, Y., Zhang, X., Zhou, Z., Shu, G., & Yin, G. (2022). Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduction and Targeted Therapy. https://doi.org/10.1038/s41392-021-00762-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.